XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Cash, cash equivalents and short term investments | -8.74%374M | -8.74%374M | -52.93%396.27M | -34.51%396.57M | -6.53%373.77M | 18.65%409.8M | 18.65%409.8M | 171.63%841.9M | 73.69%605.59M | 17.50%399.87M |
-Cash and cash equivalents | -8.74%374M | -8.74%374M | -52.93%396.27M | -34.51%396.57M | -6.53%373.77M | 18.65%409.8M | 18.65%409.8M | 171.63%841.9M | 73.69%605.59M | 17.50%399.87M |
Receivables | -6.33%948.83M | -6.33%948.83M | 3.36%968.24M | 4.22%976.44M | 9.14%983.89M | 10.18%1.01B | 10.18%1.01B | 6.88%936.8M | 5.86%936.91M | 5.51%901.51M |
-Accounts receivable | -6.33%948.83M | -6.33%948.83M | 3.36%968.24M | 4.22%976.44M | 9.14%983.89M | 10.18%1.01B | 10.18%1.01B | 6.88%936.8M | 5.86%936.91M | 5.51%901.51M |
Inventory | -9.78%1.02B | -9.78%1.02B | -0.27%1.08B | -0.55%1.1B | 0.92%1.13B | 8.44%1.13B | 8.44%1.13B | 6.09%1.09B | 14.61%1.11B | 28.92%1.12B |
Other current assets | -4.07%258.49M | -4.07%258.49M | 12.74%284.56M | 17.36%292.51M | 17.37%290.52M | 23.01%269.46M | 23.01%269.46M | 14.19%252.41M | 17.97%249.24M | 16.98%247.51M |
Total current assets | -7.85%2.6B | -7.85%2.6B | -12.35%2.73B | -4.56%2.77B | 4.11%2.78B | 11.73%2.82B | 11.73%2.82B | 28.21%3.12B | 20.23%2.9B | 17.30%2.67B |
Non current assets | ||||||||||
Net PPE | -5.95%1.05B | -5.95%1.05B | 29.71%1.03B | 33.35%1.08B | 36.37%1.1B | 39.09%1.12B | 39.09%1.12B | 5.42%797.14M | 5.64%809.16M | 3.12%804.66M |
-Gross PPE | -52.76%1.05B | -52.76%1.05B | 29.71%1.03B | 33.35%1.08B | 36.37%1.1B | 24.57%2.23B | 24.57%2.23B | 5.42%797.14M | 5.64%809.16M | 3.12%804.66M |
-Accumulated depreciation | ---- | ---- | ---- | ---- | ---- | -12.69%-1.11B | -12.69%-1.11B | ---- | ---- | ---- |
Goodwill and other intangible assets | 3.40%10.97B | 3.40%10.97B | 19.84%10.5B | 19.91%10.47B | 20.20%10.52B | 21.78%10.61B | 21.78%10.61B | 3.77%8.76B | 3.82%8.73B | 2.58%8.75B |
-Goodwill | 1.68%6.56B | 1.68%6.56B | 19.55%6.55B | 18.42%6.45B | 18.57%6.44B | 20.01%6.45B | 20.01%6.45B | 5.56%5.48B | 5.34%5.45B | 4.05%5.43B |
-Other intangible assets | 6.07%4.42B | 6.07%4.42B | 20.32%3.95B | 22.38%4.01B | 22.87%4.08B | 24.63%4.17B | 24.63%4.17B | 0.91%3.28B | 1.39%3.28B | 0.26%3.32B |
Other non current assets | ---- | ---- | 20.27%498.7M | 20.06%482.97M | 20.08%472.89M | 21.55%464.9M | 21.55%464.9M | 2.19%414.67M | 0.69%402.28M | 1.60%393.81M |
Total non current assets | -1.40%12.03B | -1.40%12.03B | 20.64%12.03B | 21.01%12.03B | 21.50%12.09B | 23.18%12.2B | 23.18%12.2B | 3.83%9.97B | 3.83%9.94B | 2.59%9.95B |
Total assets | -2.61%14.63B | -2.61%14.63B | 12.79%14.77B | 15.23%14.8B | 17.83%14.86B | 20.85%15.02B | 20.85%15.02B | 8.76%13.09B | 7.13%12.84B | 5.38%12.62B |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Payables | ---- | ---- | 5.12%576.44M | 3.97%557.11M | -4.74%603.2M | 7.49%586.16M | 7.49%586.16M | -4.35%548.38M | -6.95%535.84M | 9.49%633.2M |
-accounts payable | ---- | ---- | 5.16%511.68M | 4.67%510.46M | -1.66%517.35M | 3.91%516.59M | 3.91%516.59M | -7.19%486.58M | -9.80%487.66M | 4.33%526.06M |
-Total tax payable | ---- | ---- | 4.79%64.76M | -3.17%46.65M | -19.87%85.84M | 44.42%69.57M | 44.42%69.57M | 25.98%61.8M | 36.81%48.18M | 44.67%107.13M |
Current accrued expenses | ---- | ---- | 2.33%468.56M | 5.36%439.71M | 21.65%452.03M | 21.82%213.55M | 21.82%213.55M | 10.65%457.87M | 11.34%417.34M | 3.76%371.6M |
Current debt and capital lease obligation | -55.76%654.35M | -55.76%654.35M | 87.55%571.06M | 15,229.88%827.97M | 1,407.36%1.06B | 442.85%1.48B | 442.85%1.48B | 11.93%304.48M | -98.48%5.4M | -78.87%70.02M |
-Current debt | -53.85%654.35M | -53.85%654.35M | 87.55%571.06M | 15,229.88%827.97M | 1,407.36%1.06B | 527.18%1.42B | 527.18%1.42B | 11.93%304.48M | -98.48%5.4M | -78.87%70.02M |
-Current capital lease obligation | ---- | ---- | ---- | ---- | ---- | 31.68%61.06M | 31.68%61.06M | ---- | ---- | ---- |
Current deferred liabilities | ---- | ---- | -3.34%350.87M | -1.14%378.26M | 3.71%391.87M | 4.99%375.51M | 4.99%375.51M | 9.25%362.99M | 16.81%382.61M | 17.02%377.86M |
Current liabilities | -27.20%2.1B | -27.20%2.1B | 17.52%1.97B | 64.26%2.2B | 72.27%2.5B | 84.28%2.88B | 84.28%2.88B | 5.17%1.67B | -17.87%1.34B | -8.68%1.45B |
Non current liabilities | ||||||||||
Long term debt and capital lease obligation | -24.80%1.43B | -24.80%1.43B | -4.88%1.77B | -16.60%1.82B | -13.70%1.88B | -12.20%1.9B | -12.20%1.9B | -10.99%1.86B | 1.81%2.19B | -1.30%2.18B |
-Long term debt | -24.80%1.43B | -24.80%1.43B | -4.88%1.77B | -16.60%1.82B | -13.70%1.88B | -12.20%1.9B | -12.20%1.9B | -10.99%1.86B | 1.81%2.19B | -1.30%2.18B |
Non current deferred liabilities | 73.53%1.45B | 73.53%1.45B | 25.88%792.54M | 25.52%819.23M | 24.81%836.57M | 20.51%836.7M | 20.51%836.7M | -9.55%629.59M | -8.27%652.7M | -6.34%670.26M |
Other non current liabilities | ---- | ---- | 17.09%692.48M | 20.66%697.77M | 21.39%679.92M | 26.33%678.64M | 26.33%678.64M | 10.87%591.43M | 6.51%578.3M | 5.80%560.09M |
Total non current liabilities | -15.64%2.88B | -15.64%2.88B | 5.63%3.25B | -2.25%3.34B | -0.35%3.39B | 0.60%3.41B | 0.60%3.41B | -7.17%3.08B | 0.45%3.42B | -1.26%3.41B |
Total liabilities | -20.93%4.98B | -20.93%4.98B | 9.82%5.22B | 16.50%5.54B | 21.36%5.9B | 27.02%6.29B | 27.02%6.29B | -3.17%4.75B | -5.49%4.76B | -3.60%4.86B |
Shareholders'equity | ||||||||||
Share capital | ---- | ---- | 0.33%2.72M | 0.33%2.72M | 0.41%2.72M | 0.33%2.71M | 0.33%2.71M | 0.48%2.71M | 0.45%2.71M | 0.41%2.7M |
-common stock | ---- | ---- | 0.33%2.72M | 0.33%2.72M | 0.41%2.72M | 0.33%2.71M | 0.33%2.71M | 0.48%2.71M | 0.45%2.71M | 0.41%2.7M |
-Preferred stock | ---- | ---- | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
Retained earnings | ---- | ---- | 11.19%10.74B | 11.60%10.46B | 11.87%10.19B | 12.23%9.94B | 12.23%9.94B | 12.26%9.66B | 12.19%9.37B | 12.11%9.11B |
Paid-in capital | ---- | ---- | 7.02%1.23B | 7.70%1.21B | 8.58%1.19B | 6.80%1.17B | 6.80%1.17B | 8.41%1.15B | 7.97%1.12B | 7.26%1.09B |
Less: Treasury stock | ---- | ---- | 3.32%1.96B | 0.12%1.9B | 0.09%1.9B | -0.33%1.9B | -0.33%1.9B | -0.33%1.9B | -0.30%1.9B | 9.83%1.9B |
Gains losses not affecting retained earnings | ---- | ---- | 19.39%-457.54M | -0.08%-522.39M | 6.95%-510.33M | 15.65%-484.94M | 15.65%-484.94M | 9.62%-567.61M | 4.38%-522M | -12.94%-548.45M |
Total stockholders'equity | 10.60%9.66B | 10.60%9.66B | 14.48%9.55B | 14.49%9.25B | 15.61%8.97B | 16.77%8.73B | 16.77%8.73B | 16.96%8.34B | 16.28%8.08B | 11.91%7.76B |
Total equity | 10.60%9.66B | 10.60%9.66B | 14.48%9.55B | 14.49%9.25B | 15.61%8.97B | 16.77%8.73B | 16.77%8.73B | 16.96%8.34B | 16.28%8.08B | 11.91%7.76B |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |